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Although  the  precise mechanisms  responsible for  antibody formation  are 
unknown, it is now generally accepted that most if not all individual plasma 
cells  produce  antibodies  of  a  single  specificity  (1-5)  and  immunoglobulin 
molecules of a single allotypic type (6-8). We can therefore ask how antibody- 
forming cells of different specificities axe arranged and distributed in the lymph 
nodes and spleen.  The answer to this question may provide some insight into 
the mechanism of antibody production, and it has some relevance to the clonal 
selection  hypothesis of antibody formation  (9-11).  According to this hypoth- 
esis, a very small number of preexisting antibody-bearing cells are present in an 
animal  prior to antigen  administration.  Contact of these cells with adminis- 
tered antigen would then lead to a rapid proliferation of these cells and thus to 
the production of a large amount of that antibody initially present on the cell. 
If such  a  hypothesis were correct,  one might  expect to see,  especially soon 
after immunization,  groups or clones of plasma cells, each producing antibody 
of the same specificity,  in lymph node sections of animals immunized with two 
different antigens.  Studies of the distribution of ceils producing antibodies of 
different specificities  were first performed by White in a  brief study in  1958 
(1). He found, by employing immunofluorescent techniques in animals immu- 
nized with protein antigens,  that cells of different specificities  were randomly 
intermixed.  In contrast, in more recent studies by Braun and Nakano (12) and 
Young and Friedman (13) using the Jerne plaque technique, it was found that 
antibody-forming cells making antibodies to sheep and chicken  red blood cells 
appeared to be donally distributed in the spleens of mice. 
In the present study, the distribution in lymph node and spleen sections of 
antibody-forming  cells  of  different  specifidties  was  examined  by means  of 
double label immunofluorescent techniques.  In some experiments, guinea pigs 
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were  immunized with  two  separate  antigens, ovalbumin (OVA)  and  bovine 
"y-globulin (BGG); here the antigenic determinants are on separate molecules. 
In other experiments, animals were immunized with dinitrophenylated bovine 
~/-globulin,  or  dinitrophenylated-poly-L-lysine  bovine  serum  albumin  com- 
plexes  (DNP-PLL.BSA);  here  two  antigenic determinants are  on  the  same 
molecule  or  immunogenic  complex.  Antibody-forming cells  with  different 
specificities  were  found  both  randomly  mixed  and  separately  segregated. 
Which of these distribution patterns was obtained depended upon the method 
of immunization and the physical state of the antigens employed. 
Materials  and  Methods 
Guinea pigs (400-500 g) were obtained from Carom Research Laboratories, Wayne, N. J.; 
bovine serum albumin (BSA) and ovalbumin  (OVA) from General Biochemicals, Chagrin 
Falls,  Ohio; and bovine "/-globulin (BGG) from Armour Pharmaceutical  Co., Kankakee, 
Ill. Guinea pig T2-globulin was purified from a commercially obtained fraction II (Pentex, 
Inc.,  Kankakee, Ill.)  by passing it through a  DEAE-cellulose column equillibrated with a 
sodium phosphate buffer, .01 •  pH 7.6. Poly-TAysine  (PLL), molecular weight 115,000 was 
purchased from Pilot Chemical Co., Watertown, Mass.; Freund's complete adjuvant (CFA) 
from Dffco Laboratories, Inc., Detroit,  Mich.; and pertussis vaccine from Eli Lilly  & Co., 
Indianapolis,  Ind.  1-Fluoro-2,4-dinitrobermene (DNFB)  was  obtained  from Eastman Or- 
ganic  Chemicals, Rochester,  N.  Y.  Fluorescein isothiocyanate  (FITC)  and  tetramethyl 
rhodamine isothiocyanate  (RITC)  were purchased from Baltimore Biological Laboratories, 
Baltimore, Md.  DNP-PLL,  DNP-BGG,  and DNP guinea pig T-globulin conjugates were 
prepared by reacting the PLL or the protein with DNFB under alkaline conditions (14) and 
the degree of DNP substitution calculated as previously described (15). The subscript refers 
to the number of DNP groups per molecule. The following  conjugates were prepared: DNPs- 
BGG, DNPz6BGG, DNP~BGG, DNP25 guinea pig  T-globulin, and DNP23PLL. DNP-PLL 
albumin electrostatic  complexes were prepared  as  previously described  (5). Lymph node 
and spleen sections were made using the cold alcohol fixation and wax-embedding technique 
of Guy  Sainte-Marie (16). 
Preparation of Fluorescein- and Rkodamine-Labded Antibodies.--Rabbits  were immunized 
with BSA, OVA, BGG, or DNP6~BGG in complete adjuvant. Anti-BSA, OVA, and BGG 
antibodies were obtained from the serum as the T-globulin fraction after precipitation two 
times with 33% NH4SO4. Specific anti-DNP antibodies were isolated by the method of Farah 
et al. (17) from the serum of rabbits immunized with DNP66 BGG. The anti-BSA and anti- 
BGG antibodies were conjugated with FITC and purified on Sephadex and DEAE columns 
according to the technique of McDevitt  et al.  (18). The anti-OVA antibodies and the pure 
anti-DNP antibodies were conjugated with RITC according to the same method except that 
after  Sephadex filtration the conjugate was absorbed with charcoal as described by Nairn 
(19). 
Immunofluorescer~ Teckn/que.--The sections to be examined were dewaxed in cold xylene, 
rehydrated in graded alcohols, and finally placed in pH 7.2 phosphate buffer. The anti-BSA, 
BGG, and OVA-producing cells were detected using the Coon's sandwich technique  (20). 
BSA, BGG, and OVA at a concentration of 250 #g/ml were used as the middle layer antigens. 
The slides were then washed and treated with the appropriate fluoresceinated or rhodamine- 
labeled  antibodies.  Anti-DNP-producing  cells were detected  as  previously described  (4) 
using DNPz6BGG or DNP25 guinea pig T-globulin as the middle layer detecting antigens. 
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layer antigen. Mter  washing,  the  slides  were  treated  with  rhodamlne-labeled  anti-DNP 
antibody. 
Controls: Slides were incubated with saline instead of the middle layer antigens, the subse- 
quent steps being identical with those described above. After this procedure, no stained cells 
were seen except when fluoresceinated anti-BGG antibody was used; here a  very rare, and 
weakly stained green cell  was seen in an occasional section. 
With these techniques, in animals immunized so as to produce ceils of different specificities, 
cells of one specificity were stained green and cells of the other specificity were stained orange; 
if a  cell were producing antibodies of two different specificities it would be stained yellow. A 
detailed discussion of the validity of these methods as well as the problems assedated with 
them is given in reference 4. 
Microscopy: A Leitz Ortholux microscope equipped with an I-Ib 200 ultraviolet light source, 
a  UG-1 exciter filter, and a  GG-13 barrier filter was used. Photography was performed with 
either high speed Ektachrome daylight film or Anscochrome "SO0" daylight film. Exposure 
times were from 60 to  180  secs. 
Immunization  (general):  Animals were immunized with the antigens mixed with either an 
equal volume of complete Freund's adjuvant or an equal volume of pertussis vaccine (20 X 
109 or organisms/ml). In all the cases, the final admlni~tered volume of Freund's adjuvant- 
containing emulsion or pertussls vaccine antigen mixture was 0.1 ml/site. Animals were im- 
munized with the two separate antigens, OVA and BGG, or with antigens containing two 
determinants are on the same molecule; either DNP~BGG or DNP-PLL.BSA. 
The amount of each antigen given, sites of immunization, and time intervals between im- 
munization and sacrifice are shown in detail in the respective tables and are also discussed 
below in the section Experimental Design. 
Preparation of Heat Denatured Antigens.--OVA  or BGG solutions at a  concentration of 
10 mg/ml were added dropwise to boiling 0.15 N saline. Boiling was continued for 10 min. 
The precipitated proteins were then washed by centrifugation three times in 0.15 N saline 
and the precipitate was  diluted to  the appropriate concentration. 
Antigens Carrying Two Determinants.--Two  different antigens were used,  each of which 
carried  two  determinants on  the  same  molecule  or  immunogeuic  complex.  The  first was 
DNPr,  BGG.  It has been previously demonstrated that when animals are immunized with 
DNP-BGG conjugates bearing only a  few DNP groups, anti-DNP antibodies are produced 
as well as antibodies to the unmodified BGG carrier, and that these two kinds of antibody 
are produced in separate cells (4). 
The second type of antigen employed carrying two determinants was DNP23PLL  com- 
plexed to BSA. The immune response to DNP-PLL is under genetic control. Only 30% of 
Harfley guinea pigs can make an immune response to DNP-PLL  (21-23). However, animals 
genetically unable to respond to DNP-PLL  can be made to produce anti-DNP antibodies 
if the positively charged DNP-PLL  is electrostatically complexed to a  negatively charged 
foreign albumin. Thus, in genetic nonresponder animals DNP-PLL behaves as a hapten and 
the BSA acts as the carrier (24). After immunization of animals with this complex, anti-DNP 
antibodies are produced as well as antibodies to  the BSA. Again it had been shown that 
these antibodies are produced in separate ceils (5). The distribution of these antibody-pro- 
ducing ceils was determined both in genetic nonresponder animals immunized with DNP~3- 
PLL.BSA  (here the presence of the BSA is absolutely essential for the production of anti- 
DNP antibodies) and also in genetic responder animals immunized with DNP23PLL-BSA. 
The number, density, location, and arrangement of antibody-forming cells of each speci- 
ficity was determined by inspection; in selected cases, counts of ceils of each specificity were 
performed. The density of antibody-forming cells in the lymph nodes and spleen is described 
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as follows at a magnification of X250: lo~v density, only a few cells (24) seen per field, many 
fields contain no antibody-forming cells; moderae densily, from  15-70  cells seen per  field, 
occasional fields show no cells; high densily, several hundred cells per field, almost all areas of 
section contain antibody-forming cells. 
Anlmn]g were bled from the retroorbital plexus on the day of sacrifice and the presence of 
circulating antibody was determined by gel diffusion using Hyland Immunoplates, Pattern C, 
Hyland Laboratories, Los Angeles, Calif. Antigens were used at a concentration of 0.25 mg/ml. 
Experimental  Design 
In the animals immunized with the two separate antigens, OVA and  BGG, an attempt 
was  made to see ff varying the conditions of immunization would influence the degree of 
mixing of the cells of separate specificities. 
1. The degree of in vitro miTing of the two antigens was varied prior to injection. This 
experimental  design is shown in Table I. 
2. The two separate antigens, OVA and BGG, were not mixed in vitro but were injected 
into separate  sites,  these sites being either closely or distantly  spaced.  This experimental 
design is also shown in Table I. 
3.  Since admlni~tration of Freund's complete adjuvant produces first a  severe degree of 
hyperplasia and granuloma formation and then extensive fibrosis and distortion of the node 
architecture,  immunization of animals with BGG and  OVA in pertnssis  vaccine was  per- 
formed. Here, although hyperplasia and secondary follicle formation are prominent,  severe 
distortion of the node architecture does not take place. Again these two antigens were either 
mixed and injected into the same sites or were separated and injected into separate sites. This 
experimental design is .qhown in Table H. 
4. Another variation in the method of immunization was to make the antigen insoluble.  Here 
it was found that immunization with heat-denatured  OVA and BGG did not lead to a  sig- 
nificant degree of antibody production to soluble OVA and BGG, but  did result  in  an  im- 
mune state in these ~nlmais in which a  rapid and vigorous booster response could be elicited 
by subsequently immunizing these animals with soluble OVA and  BGG.  The  experimental 
design of these experiments is shown in Tables IV, V, VI, and VII. 
In this fourth variation of the method of immunization, the animals were therefore immu- 
nized first with the denatured OVA and BGG and then boosted with the soluble OVA and 
BGG. In order to see ff the sites of injection of the insoluble antigens would influence the 
number and distribution of each type of antibody-forming cell which resulted from boosting 
with soluble antigen,  the animals were immunized with the insoluble antigens and  boosted 
with the soluble antigens in a  variety of combinations: 
a. The insoluble antigens were injected separately on opposite sides  of the body and the 
soluble boosting antigens subsequently injected either ipsilaterally, contralaterally, or mixed. 
b.  The two insoluble antigens,  OVA and  BGG, were mixed in vitro and  injected sym- 
metrically into the four footpads, and  the soluble boosting antigens were subsequently  in- 
jected unilaterally or were mixed and injected symmetrically into the four footpads. 
As a control for the above experiment, in which the ability of immunization with insoluble 
OVA and  BGG to prepare the animal for a  booster response with soluble OVA and  BGG 
was tested, the following experiment was also performed: Animals were immunized only with 
Freund's complete adjuvant and saline; the animals were subsequently boosted with soluble 
OVA and BGG. 
In  animals  injected with antigens  containing  two determinants  on  the same  molecule, 
there was no variation in the method of imm~mization.  Antigens were always incorporated 
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RESULTS 
General Observations.--AU  the  animals  responded  with  the production  of 
antibodies  of two specitlcities as determined by fluorescein (green)  or rhoda- 
mine (orange) labeling of antibody-producing ceils. In no instance were there 
yellow plasma cells, indicating antibodies of two specificities. However,  plas- 
ma-contalnlng interstitial areas of the lymph node,  as well as the interior of 
blood vessels, were frequently stained yellow, indicating that sites containing 
antibodies of both specificities were indeed stained yellow. This is shown in 
Figs. 1 a and b. 
There  was  a  correlation  between  the  sites  of  antigen  injection and  the 
density of antibody-forming cells in the draining lymph nodes. The antibody- 
forming cell density was highest in the immediate draining lymph nodes and 
was considerably less in lymph nodes distant from the site of antigen injection. 
For example, in those animals  immunized  in the rear footpads and posterior 
flank, high antibody-formlng cell densities were present in the popliteal, flank, 
and inguinal nodes;  low cell densities  were seen in the axillary and scapular 
nodes. Examples of this observation are seen in Table II. 
In the animals immunized with Frennd's adjuvant, the density of antibody- 
forming cells in lymph node sections was far greater than that seen in animals 
immunized with the same antigen and pertussis vaccine. 
In the lymph nodes, antibody-forming  cells were seen within the diffuse cortex 
between lymphoid follicles and also in the medullary areas of the lymph node. 
An occasional antibody-forming  cell was also seen in the area of closely packed 
small lymphocytes of the lymphoid nodule. Yellow staining in a dendritic pat- 
tern due to adsorbed  "y-globulln over germinal center areas was  only rarely 
seen.  Why this type of staining was not more commonly seen is not known. 
In the spleen, antibody-forming cells were seen in the lymphoid cuffs sur- 
rounding the central arteries, and also at the periphery of lymphoid follicles in 
the red pulp. 
Distribution  of Antibody-Forming  Cells.--In  all  animals  immunized  with 
soluble OVA and BGG, either in CFA or pertussis  vaccine,  the anti-OVA- 
producing  cells and the anti-BGG-producing cells were always randomly and 
intimately mixed. This is illustrated in Figs. 2 a-c. As can be seen in Tables I 
and II, this result was not influenced by the degree of in vitro mixing of the 
antigens prior to injection or by the sites of antigen injection. 
Similar mixing of cells of different specificities was always seen in animals 
immunized with antigens bearing two determinants, and DNP~BGG  or DNP- 
PLL. BSA gave the same results  These are shown ill Table III. Accordingly, 
an attempt was made to determine the effect of a more insoluble antigen.  It 
was  found  that  animals  immunized with  heat-denatured  OVA  and  BGG 
produced no antibodies as detected by gel diffusion and only in an occasional TABLE  I 
Distribution in Lymph Node Sections of Cells Producing Anti-O~dhumin Antibodies and Cells 
Producing Anti-BGG Antibodies in Guinea Pigs Immunized with Ovalbumin and Bovine 
"y-Globulin in Complete Freund's Adjuvant 
9-2 
9-4 
9-5 
17-I 
17-3 
19-2 
19-5 
19-1 
20-3 
Method of immunization 
OVA and BGG in saline, 
mixed with CFA and in- 
jected into four footpads 
As above 
As above 
OVA in CFA, BGG  in 
CFA, mix both Freund's 
adjuvant emulsions 
gently as to give  a mar- 
ble cake effect.  Inject 
into  four  footpads 
Same as  above 
OVA in CFA, BGG  in 
CFA, each separate 
emulsion injected  into 
separate sites of same 
footpad. Four footpads 
injected 
As above 
As above 
BGG in CFA injected into 
both footpads. OVA in 
CFA injected into both 
posterior flanks 
~g 
50 
50 
50 
25 
25 
12.5 
12.5 
12.5 
25 
o 
.i 
.7 
20 
29 
29 
16 
16 
16 
16 
21 
14 
Nodes studied 
Popliteal and flank 
Popliteal and flank 
Popliteal and flank 
Popliteal,  flank, in- 
gulnal, axillary, 
and scapular 
Popliteal, flank, in- 
guinal, scapular 
Popliteal, flank, 
and scapular 
Fopliteal, flank, in- 
guinal, and scap- 
ular 
Flank, inguinal, 
axiUary, scapular, 
and popliteal 
Inguinal, flank, 
popliteal, axillary, 
and scapular 
Result 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Comment 
High cell density 
More  anti-BGG cells, high 
cell density 
More anti-BGG cells, high 
cell density 
Low to moderate cell den- 
sity 
High  cell  density,  more 
anti-OVA cells than anti- 
BGG cells 
More  anti-B GG cells  than 
anti-OVA cells 
Low cell density 
High  cell  density,  equal 
number of anti-BGG cells 
and anti OVA cells 
Moderate  cell  density.  In 
the popliteal,  flank, and 
inguinal  nodes  there 
were more anti-BGG cells 
than  anti-OVA  cells.  In 
the axiUary and scapular 
nodes  there  were  equal 
number  of  each  kind  of 
cell 
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735 
20-5 
20-1 
20-4 
20-2 
o  et 
~'~  ~  Nodes stu~ed  Method of immunization  ~  ~  . 
~.~  ~ 
As above  25  20  Inguinal, flank, 
popliteal, axillary, 
and scapular 
OVA in CFA injected into  25  18  Inguinal, flank, 
both footpads. BGG in  popllteal, axillary, 
CFA injected into both  and scapular 
posterior flanks 
As above  25  26  Inguinal, popliteal, 
upper and lower 
flank node 
As above  25  26  Inguinal, flank 
Result 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termlx~ 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Comment 
Low cel  ! density. The anti- 
BGG ceils were more nu- 
merous  than  anti-OVA 
cells in all nodes.  In axiL 
law  and  scapular  node~ 
very few  antibody form. 
ing cells were seen 
Moderate to high cell den. 
airy.  In  the  popliteal~ 
flank, and inguinal node~ 
the  anti-OVA  cells wer~ 
more numerous than anti. 
BGG cells. In the axillar~ 
node  the anti-BGG cell,~ 
were more numerous that 
the anti-OVA cells 
Moderate  cell  density 
Equal  numbers  of  anti. 
OVA cells and anti-BGG 
cells  were  seen,  excepl 
that  in  the  lower  fla~ 
node  there  were  mort 
anti-BGG cells than anti. 
OVA cells 
Moderate  cell  density.  II 
the flank node many morq 
anti-OVA cells than anti. 
BGG cells 
animal were a few weak anfi-BGG-producing cells seen in lymph node sections. 
In no case were anti-OVA-producing cells found.  These results are shown in 
Table 1V. 
However,  other  animals  immunized  with  insoluble  OVA  and  BGG  were 
then boosted with soluble OVA and BGG. This lead to the appearance of a 
large number of antibody-forming cells in the lymph nodes and spleen and to 
the presence of detectable anti-BGG and anti-OVA antibodies in the serum of 
these animals. These results are shown in Tables V and VI. In the first set of 
these experiments shown in Table V, the animals were immunized first with 
insoluble OVA in the right half of the body and with insoluble BGG in the left TABLE  H 
Dis~r~ution in Lymph Node Sections of Cells Producing Anti-Ovalbumin Antibodies and Cells 
Producing  Anli-BGG  Antibodies  in  Animals  Immunized  with  Ovalbumin  and  Bovine 
T-Globulln w@h Pertussis  Vaccine 
31-1 
31-2 
31-3 
31-4 
31-5 
30-1 
30-5 
30-2 
Method of immunisation 
OVA and BGG in saline 
mixed with equal vol- 
tunes of pertmsls vac- 
cine.* mixture injected 
into four footpads 
As above 
As above 
As above 
As above 
OVA in saline  mixed  with 
equal volume of  pertus- 
sis  vaccine,  injected  into 
posterior flank. BGG in 
saline mixed with equal 
volume pertnssis vacHn¢ 
injected into rear foot- 
pads 
As above 
OVA in saline mixed with 
equal vohtme of pertus- 
sis vaccine, injected into 
rear footpads. BGG in 
saline mixed with equal 
volume pertussis vac- 
due, injected into pos- 
terior flank 
m °i 
[  m 
#g 
50  13 
50 
50 
50 
50 
50 
50 
50 
13 
16 
16 
19 
I0 
19 
10 
Nodes studied 
Flank, popliteal, 
axillary and scap- 
ular 
Flank, axillary,  and 
scapular 
Flank, scapular, and 
pupliteal 
Flank, scapular,  and 
popllteal 
Flank, scapular, and 
popliteal 
Flank, inguinal, 
popliteal, axillary, 
and  scapular 
Popllteal and flank 
nodes 
Popliteal, fi~nlr  and 
axillary 
Result 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells  of  each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
terrnixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Comment 
More anti-BGG  cells  than 
anti-OVA cells  except in 
one  node  where  there 
were  equal  numbers  of 
both kinds of cells 
More  anti-OVA  cells  than 
BGG cells 
Moderate cell density, more 
anti-OVA cells than anti- 
BGG ceils 
Low  cell  density,  more 
anti-OVA ceils than anti- 
BGG cells 
Moderate  cell  density.  A 
large number of anti-OVA 
cells were present plus a 
few anti-BGG cells 
Low cell density.  In  flank 
node more antiOVA cells 
than  anti-BGG  cells.  In 
popllteal node more anti- 
BGG cells than anti-OVA 
cells;  axnlary and  scap- 
ular nodes did not show 
antibody-forming cells 
Low  cell  densities  in  the 
flank and popliteal nodes; 
anti-OVA  cells  outnum- 
bered the anti-BGG cells 
Antibody-forming  cells were 
seen  only  in  flank  node 
and  axillary  node.  In 
flank  node  cell  density 
was  moderate,  in  this 
node  some  areas  anti- 
BGG cells were more nu- 
merous  in  other  areas 
anti-OVA cells were more 
numerous.  Axi]lary node 
had a low density of anti- 
OVA and anti-BGG cells, 
weakly stained 
* 20 X  lo  9 organisms/inf. 
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737 
30..3 
304 
[ As above  50  15  Flank, axillary, and 
popllteal 
As above  50  15  Flank, popliteal, 
and scapular 
Result 
Cells of each 
specificity in- 
termixed 
Only anti-OVA 
cells were 
seen 
Comment 
Axlllary  and  poplitesl 
nodes  had  low  cell  den- 
sities.  Two  flank  nodes 
were found, in one  node 
anti-BGG  cells  outnum- 
bered  anti-OVA cells by 
20:1,  in  the  other  node 
this ratio was reversed 
Low  cell  densities.  Scap- 
ular  node  had  no  anti- 
body-forming  cells. Flank 
and popllteal  nodes  had 
only antLOVA-produdng 
cells 
half of the body; these animals were then subsequently boosted with soluble 
OVA and BGG. The soluble antigens were given either ipsilaterally or contra- 
laterally in respect to the first immunization, or were given mixed together. As 
can be seen, the ratios of the numbers of BGG to OVA cells in the nodes in the 
fight and left sides of the body bore no constant relationship to the sites of 
either the first or second immunization. In general there were more anti-BGG 
cells  than anti-OVA cells.  Here, however, for the first time in four of these 
eight animals, lymph nodes were found in which some areas of the node showes 
cells of a  single specificity grouped together. This is illustrated in Figs. 3 a-b 
and Figs. 4  a-c.  In the spleens of these animals, cells of different specificitied 
were always randomly mixed. 
In the next set of experiments, with insoluble antigens, shown in Table VI, 
the insoluble OVA and BGG were mixed together and injected symmetrically 
into the four footpads. The animals were then boosted with soluble OVA and 
BGG either symmetrically or asymmetrically. Again there was no constant 
relationship between the ratios of the anti-BGG cells to anti-OVA cells in terms 
of the sites of either the first or second antigen injections. However, in three of 
these six animals, lymph nodes were again found which in some areas showed 
cells  of one specificity grouped together. As in the previous experiment, the 
spleens  of these  animals showed cells  of different specificities to be  always TABLE  HI 
Distribution  in Lymph Node Sections  of Cells Producing  Antibodies  to Two Separate 
Determinants  on the same Antigenic Molecule 
Animal No. 
23-1, genetic  non- 
responder animal 
25-1, genetic non- 
responder animal 
25-2,  genetic  non- 
responder animal 
25-A, genetic re- 
spender animal 
25-B, genetic re- 
sponder animal 
25-C, genetic re- 
sponder animal 
34-5 
~4-1 
34-2 
Days 
Antigen and  after 
method of  immu- 
immunization  niea- 
tion 
Nodes studied 
DNP-PLL.BSA*  18  Popliteal, axillary, 
in CFA 200 IJg/  flank 
animal, four 
footpads injected 
As above  13  Inguinal, popllteal, 
scapular 
As above  13  Inguinal, poplitea], 
scapular, axil- 
Isry, flank 
As above  19  Axillary and in- 
guinal 
As above  19  Flank, popliteal, 
and scapular 
As  above  19  Flank, popliteal, 
and axillary 
15  Flankand inguinal  DNPsBGG~ in 
CFA 100 ~g/anl- 
real, injected in 
four footpads 
As above  24  Flank, inguinal, 
popliteal, and 
Scapular 
As above  24  Flank, popliteal, 
and scapular 
As above  26 
As above  36 
As above  36 
Popliteal,~nk, 
scapular,  and 
axillary 
Inguinal, flank, 
axillary, and pop- 
liteal 
Inguinal, axillary, 
flank, and pop- 
liteal 
Resul  t 
Cells of each 
specificity in- 
termixed 
Cells  of  e~ch 
specificity  in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specifidty in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells of each 
specificity in- 
termixed 
Cells  of each 
specificity in- 
termixed 
Cells of each 
specificity  in- 
termixed 
Cells of each 
specifidty  in- 
termixed 
Comment 
High cell density 
Low cell density 
Moderate cell density 
Moderate cell density, anti- 
DNP cells more numerous 
than anti-BSA cells 
Moderate cell density, num- 
ber of DNP cells and anti- 
BSA cells were equal 
Low cell density. The num- 
ber of anti-DNP cells and 
anti-BSA cells are equal 
High to moderate cell den- 
sity, anti-BGG cells out- 
number  anti-DNP  cells 
High  cell  density.  Anti- 
BGG  cells  outnumber 
anti-DNP  cells  by  ratio 
10:1 
Moderate cell density. Anti- 
BGG cells are  more nu- 
merous  than  anti-DNP 
cells 
Moderate to high cell den- 
sity. Anti-BGG cells out- 
number  anti-DNP  cells 
by ratio of 10:1 
Moderate cell density. Anti- 
BGG  cells  outnumber 
anti-DNP  cells  by  ratio 
of 20:1 
Moderate  density.  Anti- 
BGG  cells  outnumber 
anti-DNP  cells  by  ratio 
of 20:1 
* Here the animals produce anti-DNP-PLL antibodies and anti-BSA antibodies (see reference 5). 
Here the animals produce anti-DNP antibodies and antibodies to the determinants on the BGG molecule (see refer- 
ence 4). 
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randomly  mixed.  All these animals  made anti-OVA  antibody and anti-BGG 
antibody as detected by gel diffusion. 
To determine the degree of response to soluble antigens  alone in animals not 
previously  immunized  with insoluble  antigens,  a  group  of five animals  was 
injected with only saline in CFA. They were then boosted with soluble  OVA 
and BGG as shown in Table VII. Here, only a few antibody forming cells were 
seen and  no anti-OVA  or anti-BGG  antibodies  were detected in the sera of 
these animals by gel diffusion. Thus, immunization with these insoluble protein 
antigens produces an immune  response characterized  by little or no antibody 
TABLE IV 
E2~ec~ of Immunizing  Guinea Pigs with Hea~D~ured Ovalbumin and Heat-Dena~sd Bovine 
T-Globulin 
No.  of 
Animals  Immunizing Antigen 
Denatured OVA and denatured 
BGG in CFA, 50 •g/site/an- 
tigen. Antigens given either to- 
gether at same site or sepa- 
rately into footpads and pos- 
terior flanks 
Denatured OVA and denatured 
BGG mixed with pertuesis 
vaccine, 50 ~g/site/anti- 
gen. Antigens given either to- 
gether at same site or injected 
separately  into  footpads  and 
posterior  flanks 
Days after 
immtmlza- 
tion 
13-14 
13-14 
Over-all result* 
In  three  fmlm~.tls  a very  few  weakly 
stained anti-BGG  cells were 
seen  in  lymph node sections.  No 
anti-BGG  or  anti-OVA  anti- 
bodies  were  detected by  gd 
diffusion 
No  antibody  forming-cells  seen. 
No  anti-BGG  or  anti-OVA 
antibodies  were detected  by gel 
diffusion 
* Popliteal,  flank,  inguinal,  axillary,  and scapular  nodes examined. 
production but one which prepares the animal for a vigorous booster response 
to soluble antigens. 
DISCUSSION 
The  observations in  the present study are in agreement with  the concept 
that  individual  antibody-forming cells  produce  antibodies  of a  single  speci- 
ficity. In addition, it was found that cells responding to different soluble anti- 
gens were always randomly intermixed.  These results were obtained whether 
the animals were immunized with the soluble OVA and BGG mixed together 
in varying degrees or whether the soluble OVA and BGG were injected sepa- 
rately into closely or distantly separated sites.  Identical, random intermixing TABLE  V 
Effec~ of Immunising Guinea Pigs ~h  Heat-Denatured Ovalbumin and Heat-Denatured Bovine 
~y-Globul~n on Opposite Sides of ~he Body Follo~ved by Ipsilaleral, Conlralaleral, and Mixed 
Boosting wilh  Soluble Ovalbumin and  Soluble Bovine T-Globulin 
39-1 
39-5 
39-2 
39-? 
$9-3 
Animal! First immunizing  Inter- 
NO. it  antigen  val 
days 
Right: Denat.  10 
OVA 30 ~g/site 
in CFA right 
paw and right 
footpad 
Left: Denat. 
BGG 50/~g/ 
site in CFA 
left paw and 
left footpad 
As above  10 
As above  10 
As above  10 
As above  10 
Days 
after 
Second  first 
immu-  Distribution of cells of 
immunizing  nization  each specificity 
antigen  nodes 
exaJmt- 
ined 
Right: Soluble  17  Right:* Mixed 
OVA I0 ~g in 
right paw and 
right footpad  Left:* Mixed 
Left: Soluble  Spleen: Mixed 
BGG 10 ~g in 
left paw and 
left footpad 
As above  20 
Right: Soluble 
BGG 10 ~g in 
right paw and 
right footpad 
Left: Soluble OVA 
10 #g in left 
paw and left 
footpad 
As above  20 
Right: Soluble 
OVA and BGG 
mixed, 10 ~g/ 
each per foot 
pad 
Left: Soluble OVA 
and BGG 
mixed, 10 ~/ 
each per foot- 
pad 
Right: Mixed 
Left: Mixed 
Spleen: Mixed 
Right: Mixed except in 
axillary and scapular 
node there was same 
grouping of anti-OVA 
cells 
Left: Mixed in general, 
however, in axillsry 
and scapular nodes 
there was grouping of 
anti-OVA cells 
Spleen: Mixed 
Right: Generally mixed, 
however, in inguinal 
and  flank node  there 
were separate areas of 
anti-OVA  and  sepa- 
rate areas of anti-BGG 
Left: Generally mixed, 
however,  in  left  pop- 
liteal node there were 
areas of all anti-BGG 
cells 
Spleen: Mixed 
20  Right: Mixed 
Left: In general mixed, 
but  in  left  inguinal 
node there were areas 
of only anti-0VA cells 
Spleen: Mixed 
Density of cells 
High to moder- 
ate 
H~b 
Moderate 
High 
H~h 
Low 
High 
High 
Moderate 
Moderate 
Moderate 
Moderate 
High 
High 
Moderate 
Over-all 
ratio 
Anti- 
BGG 
cells: 
Anti- 
OVA 
cells 
2:1 
5:1 
4:1 
1.5:1 
5:1 
10: I 
2:1 
10: I 
2:1 
1.5:1 
1:6 
1:1 
6:1 
10:1 
20: I 
* In all cases right and left poplitesl, flank, inguinal, axillary, and seapuIar nodes were examined. 
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Animal  First immunizing 
l~o.  antigen 
39-8  As above 
39-9  As above 
19-10  As above 
Inter- 
val 
days 
10 
10 
10 
Days 
after 
Second  first 
immu- 
immunizing  nizafion 
antigen  nodes 
exam- 
ined 
As above  20 
As above  20 
As above  20 
Distribution of cells of 
each specificity 
Right: Mixed, but in 
right axillasy and scap- 
ular node  there  were 
areas of only anti-OV.~ 
and areas of only anti- 
BGG 
Left: Mixed, but in in- 
guinnl node there were 
areas of only one or the 
other type of cell 
Spleen: Mixed 
Right: Mixed 
Left: Mixed 
Spleen: 
Right: Mixed 
Left: Mixed 
Spleen: Mixed 
Density of cells 
Moderate 
Moderate 
Moderate 
Moderate to low 
Moderate to low 
Low 
Low 
Low 
Moderate 
Over-nil 
ratio 
Anti- 
BGG 
cells: 
Anti- 
OVA 
cells 
1:1 
2:1 
3:1 
1:2 
1:1 
1:1 
2:1 
1:1 
3:1 
of cells of different specificities was obtained in animals also immunized with 
antigens in which the two antigenic determinants were on the same molecule 
or immunogenic complex. 
However,  when animals  were immunized with heat-denatured particulate 
OVA and BGG and then boosted with soluble OVA and BGG a  somewhat 
dififerent result was obtained.  Here, although cells of different specificities were 
also found to be intermixed in some lymph nodes, other lymph nodes in the 
same animal often showed areas in which cells of one specificity were grouped 
together. Of interest was  the fact that animals immunized  only with heat- 
denatured OVA and BGG produced very few anti-BGG cells and no anti-OVA 
cells, yet such animals were prepared for a rapid booster  response to soluble 
OVA  and  BGG.  Gell  and  Benacerraf  (25) had  previously observed  that, 
although animals immunized with heat-denatured proteins produced no anti- 
body to the soluble forms of these proteins, they did manifest delayed reactions 
to the soluble  proteins.  Steiner  and Eisen  (26) recently demonstrated that 
injection of hapten protein  conjugates in rabbits,  in  amounts too small to 
elicit  detectable  antibody formation, nevertheless  prepared  the  animal for 
partial secondary response. 
Another  observation  which  was  made  was  that  in  animals  immunized 
unilaterally with the priming insoluble  antigens OVA  and  BGG,  and  then 
boosted  with  the  soluble  antigen  either  ipsilaterally  or  contralaterally or TABLE  VI 
Effect of Immunizing Guinea Pigs witk Heat-Denatured Ovalbumin and Heat-Denalured Bovine 
T-Globulin in  tke  Four  Footpads Followed by  Asymmetric  or Symmetric  Boosting  with 
Soluble Ovalbumin and Soluble Bovine "7-Globulin 
Animal 
No. 
43-2 
43-6 
43-7 
43-8 
43-I 
43-5 
First immunizing  Inter- 
antigen  val 
i-~-y, i 
Insoluble OVA  9 
and insoluble 
BGG mixed, 
50/~g each in 
CFA injected 
into the four 
footpads 
As above  9 
As above  9 
As above  9 
As above  9 
As above  9 
Second 
immunizing 
antigen 
Right: Soluble 
OVA 10 ~g in 
right paw and 
footpad 
Left: Soluble 
BGG 10 ~g in 
left  paw and 
footpad 
As above 
As above 
As above 
A mixture of sol- 
uble OVA and 
soluble BGG 
was injected 
symmetrically 
into the four 
footpads. 10 I-~ 
each antigen/ 
site 
As above 
Distribution of cells  of 
each specificity 
Right:* Mixed 
Left:* Mixed 
Spleen: Mixed 
Right: Generally mixed, 
but in popliteal and 
flank node there were 
areas of only anti-OVA 
cells 
Left: Generally mixed, 
but in flank node there 
were areas of only anti- 
OVA cells 
Spleen: Mixed 
Right: Generally mixed, 
but in inguinal and 
axillary  nodes  there 
were areas of each kind 
of cell 
Left: Generally mixed, 
but  in  axillary  node 
there  was an  area of 
only anti-BGG cells 
Spleen: Mixed 
Right: Mixed 
Left: Mixed 
Spleen: Mixed 
Right: Mixed 
Left: Mixed 
Spleen: Mixed 
Density of cells 
High 
High 
Moderate 
Moderate to 
high 
Moderate 
Moderate 
Low to moder- 
ate 
High 
Moderate 
Moderate 
Low to moder- 
ate 
Low 
~h 
High 
Moderate 
Right: Mixed 
Left: Mixed, however, 
in  flank  node  there 
were  areas  of  only 
anti-OVA cells 
Spleen:  Mixed 
Moderate 
Moderate to low 
Low 
Over-all 
ratio 
Anti- 
BGG 
ceils: 
Anti- 
OVA 
ceUs 
2:1 
1:1 
8:1 
1:2 
2:1 
1:1 
1:3 
1:4 
1:3 
1:7 
1:7 
1:10 
2:1 
2:l 
3:1 
1:! 
1:1 
2:1 
• In all cases right and left popliteal, flank, inguinal, mdl]ary, and scapular nodes were examined. 
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mixed, there was no constant relationship found between the number of anti- 
body-forming cells of each specificity  in  the draining lymph nodes and the 
sites  of injection of the first insoluble  antigen or the second soluble antigen. 
Similar  findings confirming the wide dissemination of "memory ceils" during 
TABLE VII 
~ffect of Immunizing Guinea Pigs vA~h Saline in Freund's Adjuranl  Followed by 
Boosting ~th Soluble OVA  and  BGG 
Second immunizing antigen 
Soluble OVA right foot pad 
and right paw 25 ~g/slte 
Soluble BGG left footpad 
and left paw 25 ~g/site 
As above 
Soluble OVA and soluble 
BGG mixed and injected 
into the four footpads. 
25 ~/site for each antigen 
As above 
As above 
Over-allresult* 
Only a very rare anti-BGG cell seen. N'o 
antibody-forming cells  seen in spleen 
Density of antibody forming cells  very 
low. In right popliteal node OVA cells 
were more numerous than anti-BGG 
cells. In other areas of this node anti- 
BGG cells were more numerous. Nodes 
on  left  side  of body contained only 
anti-BGG cells--spleen had no anti- 
body fo~in~ cells 
Density of antibody-forming cells  was 
low to moderate. Anti-BGG cells were 
more numerous than anti-OVA cells-- 
spleen contained a rare anti BGG cell. 
Cells of each specificity  were mixed 
Density of antibody forming cells  was 
low,  BGG cells  were more numerous 
than  anti-OVA  cells,  except  in  left 
popliteal and axillary nodes anti-OVA 
cells  were more numerous.  Cells  of 
each  specificity  were  mixed--spleen 
contained no antibody  forming cells 
Density of  antibody-formlng cells  was 
low.  Anti-BGG cells  were more nu- 
merous than  anti-OVA cells.  Spleen 
had a very few anti-BGG cells.  Cells 
of each specificity  were mixed 
* Right and left popllteal, flank, inguinal, axillary scapular nodes, and spleen examined. No anti-OVA anti- 
body or anti-BGG antibody detected by gel diffusion in any animal. 
later phases of the immune response have been reported by Hall et al.  (27) as 
well as by Steiner and Eisen (25). Nevertheless, in agreement with the previous 
investigators, the present data indicate that,  early in the antibody response, 
the  nodes immediately  draining  the  sites  of antigen  injection  are  the most 
active in antibody production, and the distant nodes are less active (28-30). 744  ANTIBODY-:FORMING  CELLS  IN  LYMPH  NODE  AND  SPLEEN 
The  earlier  observations  of Askonas  and  White  (31),  which  indicated  that 
antibody production was more pronounced in nodes distant  from the site of 
antigen injection, may have been due to the relatively large amounts of antigen 
administered  (5 rag/site)  and  thus  local  tolerance may have been produced 
(32). 
Attempts to understand the mechanisms of antibody formation can be made 
at various levels. The present data apply best, perhaps, to the question whether 
the cell destined to produce a specific antibody in large amounts is a descendant 
of a  cell precommitted to making this antibody, by virtue  of having a  small 
amount of the antibody on its surface prior  to antigen  administration.  This 
restates the clonal  selection  hypothesis, which  presumes proliferation of such 
committed cells in response to corresponding antigen.  In addition, proponents 
of this view explain the kinetics of antibody formation as well as the changes  in 
affinity of the antibody with time and amount of antigens administered, by the 
competition  for  antigen  by cells  bearing  antibodies  of  different  preexisting 
affinities (33-35). 
Another view based upon a variety of physiological  (36-40), morphological 
(41, 42),  and  theoretical considerations  (43, 44)  would suggest the  possibility 
that  a  cell  destined  to make  an  antibody could have made  any  antibody. 
According to this view, the mechanism of antibody formation is more compli- 
cated  and  may entail  a  series  of steps,  each  being performed  by cells  of a 
different lineage  and  function.  The initiation  of the immune response being 
performed by cells derived from the thymus, the final production of an anti° 
body occurs in cells derived from another cell lineage,  the bone marrow (38, 
45). The products of this first interaction  (be they an antigen-RNA complex, 
a viral particle, or episome)  then transform uncommitted cells into cells which 
can produce specific antibodies.  Whether this comes about as the result of a 
selection  process at  a  subcellular  level  or  by entirely  different mechanisms 
must  remain  a  matter  for  conjecture.  Other  evidence,  recently  obtained, 
suggests that  the initiation  of the immune response depends on a  processing 
step which appeared to be genetically controlled,  and the specificity of which 
may be different from that of the antibody which is later to be produced in the 
immune response (46). 
The basic observations of the present paper and those o1 previous authors 
(12, 13) indicate that, in animals  given two different particulate antigens such 
as sheep and chicken  RBC or insoluble particulate OVA and BGG, antibody- 
forming cells of each separate specificity appear to occur in separate groups.  In 
animals  ~mmunized  with  two  different  soluble  protein  antigens,  antibody- 
forming  cells  of different specificities  are randomly intermixed  as shown by 
White (1) and confirmed  here.  These results suggest that the precursor cell is 
multipotential  and  that  the  microenvironmental  site  of  deposition  of  the 
antigen  (and therefore the site of the early processing  step) determines where IRA G~E~  745 
antibody-forming cells of each specificity subsequently appear. It is reasonable 
that the soluble antigens become widely distributed and therefore the sites of 
processing  are also widely distributed; insoluble antigens are more irregularly 
and less finely deposited. In the context of the present experiment, the injection 
of these particulate  antigens would thus lead to focal and irregularly placed 
collections of cells capable of efficiently processing  the soluble antigen which is 
given later. It must also be assumed that the products of the antigen-process- 
ing interaction must act at only very short distances and/or require actual cell 
to cell  contact,  as depicted for example by Thiery  (41)  and  by McFarland 
et al. (42). 
Also,  although  most investigators  agree  that  antigen  is not detectable in 
antibody-forming  cells,  (47, 48),  and  that  antigen-containing  macrophages 
may have no fixed relationship to any individual antibody-forming cells, the 
fact remains that large numbers of macrophages (but not the dendritic mac- 
rophages of the germinal center) and antibody-forming cells are found in  the 
same general area of lymph nodes and spleen,  namely in the areas immedi- 
ately peripheral to the dense lymphoid nodule and in the medullary cords of 
lymph nodes and red pulp of the spleen (48-50). 
The presence of areas of cell intermixing,  as well as clusters of cells of single 
specificity in the lymph nodes of animals immunized with the two insoluble 
antigens  followed  by boosting with  the  two soluble antigens,  can  be inter- 
preted  to mean  that  some cells  capable of processing  antigen  have become 
disseminated throughout  the lymphoid system late in the immune response. 
The failure to find cell clusters of single specificity in the spleen of such ani- 
mals--a  site  distant  from  the  site  of  initial  immunization--supports  this 
idea. 
If antibody production were based on the selection of a small number of pre- 
committed cells followed by rapid proliferation of these cells, animals  immu- 
nized with two separate antigens should have produced clones or group of cells 
of a single specificity,  both in animals  immunized with either soluble or insol- 
uble antigens.  Thus the observation made in this as well as in previous studies 
would favor the idea that which antibody is produced by a cell is determined 
by the location of that cell in relationship to the site of antigen processing.  The 
production of a single antibody by each individual cell may therefore not be 
based on a precommitment, but rather preemption of the uncommitted cell by 
the postulated product of this antigen processing  (51). The data do not clarify 
how the tremendous diversity of antibody structure is established at the level 
of the DNA, or whether after the initial interactions the persistence of some 
antigen is necessary for long continued antibody production. 
Another  observation  which  does not  fit  simple  cell  selection  by antigen 
theories is that animals immunized with very small amounts  of antigen  (26), 
or insoluble antigens,  produce little or no antibody; yet such animals,  after a 746  ANTIBODY-FORMING  CELLS IN LYMPH NODE AND SPLEEN 
booster injection of antigen,  can rapidly form large amounts of antibody.  This 
antibody also has a higher  affinity than  would have been expected to result 
from the boosting injection alone.  The proposed mechanism for this phenom- 
enon is the development of cell populations capable of binding antigen as the 
result  of  the  initial  immunization.  If  such  postulated  cell  populations  are 
developed,  following  immunization  with  small  amounts  of antigen  or  insol- 
uble antigens,  and are the basis for later cell selection by the boosting antigens, 
these cells are not detectable by current techniques.  The alternative explana- 
tion  of this  phenomenon  would be that  the priming  effect of immunization 
with very small amounts of antigen or heat-aggregated protein antigens might 
act  by an  amplification  and  increase  in  efficiency  of the  antigen-processing 
mechanism, rather than the production of antibody-forming cells. 
Finally, this study has again shown that when animals  are immunized  with 
antigenic  molecules  bearing  two  separate  determinants,  the  antibodies  to 
these different determinants are made in separate cells. This fact alone suggests 
that the interaction of antigen with the antibody-forming mechanism is prob- 
ably more complicated than simple cell selection  by antigen. 
SUMAq~Ry 
The distribution of antibody-forming  cells  of different specificities  in the 
lymph nodes and spleens  of guinea pigs  immunized with two separate antigens 
or with antigens bearing two determinants  was studied. When animals were 
immunized  with two soluble protein antigens or antigens in which the two 
antigenic determinants  were on the same molecule, antibody-forming  cells  of 
different specificities  were always randomly intermixed. However,  when ani- 
mals were immunized  with two heat-aggregated particulate protein antigens 
and then boosted with soluble  protein antigens, cells  of different  specificities 
were often seen to occur in groups. 
These results suggest that antibody-forming  cells may  not arise by the 
antigen-stimulated  proliferation of  precommitted  antibody-forming  cells, 
but rather antibody-forming  cells  arise  by a transformation of uncommitted 
precursor cells  as the result  of their  interactions  with a locally  produced ma- 
terial  derived from the processing of antigen. 
I would like to thank Patricia Kaplerchuk for her expert technical assistance. 
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FIO. 1 a and 1 b. Sections from  scapular lymph node  of  animals 19-5 (Table  I) 
immunized with soluble OVA and BGG in CFA.  Orange cells  are producing anti- 
OVA antibody and green cells are producing anti-BGG antibody. Blood vessels and 
interstitial plasma-containing areas are  stained yellow due to the presence of anti- 
bodies of both specificities. Moderate cell density. Anscochrome "500."  ×  338. 
FIG. 2 ~. Section from flank node of animals 9-2 (Table I) immunized with soluble 
OVA and BGG in CFA. Orange cells are producing anti-OVA antibody and green 
cells are producing anti-BGG antibody, cells of each  specificity  are randomly mixed. 
High cell density. High speed Ektachrome.  X  63. 
FIG. 2 b. Section from flank node of animals 9-5 (Table I) immunized with soluble 
OVA and BGG in CFA. Cells of each specificity are randomly mixed. High cell density. 
High speed  Ektachrome.  ×  156. 
Fro. 2 c. Section from popliteal node of  animal 17-3 (Table I)  immunized with 
soluble OVA and BGG in CFA. Cells of each  specificity  are randomly mixed. High 
speed  Ektachrome.  X  104. 
Fins. 3 a and 3 b show two different areas from the same section of the left inguinal 
node from animal number 39-3 (Table V) immunized first with heat-aggregated par- 
ticulate OVA  and BGG followed  by boosting with soluble OVA and soluble BGG. 
Fig. 3 a shows mainly orange anti-O~\4-producing  cells. Fig. 3 b shows only green anti- 
BGG-producing  cells. Figs. 3 a and 3 b show a moderate cell density. Taken with high 
speed  Ektachrome.  ×  104. 
FIGS. 4 a, 4  b, and 4 c show three different areas from the same section of the right 
inguinal lymph node of animal 39-7 (Table V) immunized first with heat-aggregated 
particulate OVA and BGG followed by boosting with soluble OVA and BGG. Fig. 4 (z 
shows many green anti-BGG--producing  cells and a rare orange anti-OVA-producing 
cell. Fig. 4 b shows an area where the anti-OVA cells and anti-BGG cells are randomly 
mixed.  Fig.  4 c shows  an area  containing mainly orange anti-OVA-producing cells. 
There is a moderate cell density in Figs. 4 a and 4 c and a high cell density in Fig. 4 b. 
High speed  Ektachrome.  ;4  104. 
It should be noted that the color values seen in the prints do not adequately repre- 
sent the colors actually seen.  This is especially true when high speed  Ektaehome is 
used; here orange cells appear yellow. ?Sl 